Antiviral Drug News and Research

RSS

H5N1 genetic mutation observed in Egypt

Viruses with a genetic mutation, linked in laboratory testing to moderately reduced susceptibility to oseltamivir, have been discovered in two persons previously reported with H5N1 infections in Egypt.

22 Jan 2007

Viral Genetics identifies two key peptides for potential HIV/AIDS drug

Viral Genetics has identified two key peptides involved in its thymus nuclear protein or "TNP" technology currently under development for the treatment of HIV/AIDS.

9 Jan 2007

HHS and BioCryst advance development of new influenza drug

HHS Secretary Mike Leavitt announced that the Department has awarded a $102.6 million, four-year contract to BioCryst Pharmaceuticals, Inc. for advanced development of their influenza antiviral drug, peramivir.

7 Jan 2007

Canada says warnings needed on bird flu drug Tamiflu

Canadian health authority Health Canada has requested that the manufacturer of the antiviral drug Tamiflu place warnings on it's labels of adverse effects.

1 Dec 2006

Bird flu hits another farm in South Korea

A second outbreak of the virulent H5N1 strain of bird flu at another poultry farm has been confirmed by South Korean authorities; the farm is just 3 km from the first case in North Cholla province in the country's southwest.

29 Nov 2006

New bird flu drug will provide new line of defence

Flu experts say a new flu drug with the ability to kill deadly strains of bird flu promises to provide a much needed third option should a pandemic occur.

28 Nov 2006

Experts say Britain vulnerable to bird flu pandemic

Experts in Britain believe the government should have stockpiled more than one antiviral drug in order to tackle a bird flu pandemic and say Britain has been left vulnerable because the stockpile of anti virus drugs is deficient.

20 Nov 2006

Brookhaven target compounds to fight SARS

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002.

20 Nov 2006

Brookhaven target new anti-SARS virus drugs

Scientists at Brookhaven National Laboratory have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002.

14 Nov 2006

Liver damage can be reversed

Saint Louis University Liver Center scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current drug therapies.

30 Oct 2006

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

The Food and Drug Administration (FDA) has approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a serious viral infection that attacks the liver and can cause lifelong infection, scarring of the liver (cirrhosis), and eventually liver cancer, liver failure, and death.

26 Oct 2006

Vaccine that protects mice against 1918 influenza virus developed

Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus. They also have created a technique for identifying antibodies that neutralize this virus, a tool that could help contain future pandemic flu strains.

17 Oct 2006